INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, INSTITUT REGIONAL DU CANCER DE MONTPELLIER, NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY, UNIVERSITE DE MONTPELLIER FILES APPLICATION FOR "ANTIBODIES HAVING SPECIFICITY TO TGFBI AND USES THEREOF"

GENEVA, Nov. 3 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), INSTITUT REGIONAL DU CANCER DE MONTPELLIER (208, Rue Des Apothicaires - Parc Euromedecine34298 Montpellier), NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (2 Aramaki-machi 4-chomeMaebashi-shi, Gunma, 3718510), UNIVERSITE DE MONTPELLIER (163, rue Auguste Broussonnet34090 Montpellier) filed a patent application (PCT/EP2025/061321) for "ANTIBODIES HAVING SPECIFICITY TO TGFBI AND USES THEREOF" on Apr 25, 2025. With publication no. WO/2025/224297, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which ...